Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Phase II Open Label, Study of IMMU-132 in Metastatic Urothelial Cancer

Multiple Cancer Types

This is an international, multi-center, open-label, phase II study in patients with metastatic urothelial cancer after failure of platinum-based regimen or anti-PD-1 / PD-L1 based immunotherapy. At least 321 patients are anticipated to be enrolled across approximately 40 sites from North America and Europe.
Bladder, Urologic
Davis, Nancy

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: